We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

216 hedge funds and large institutions have $1.35B invested in Meridian Bioscience Inc in 2022 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 67 increasing their positions, 73 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

459% more call options, than puts

Call options by funds: $5.9M | Put options by funds: $1.05M

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

50% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 22

21% more capital invested

Capital invested by funds: $1.11B → $1.35B (+$232M)

3% more funds holding

Funds holding: 210 → 216 (+6)

8% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 73

Holders
216
Holders Change
+6
Holders Change %
+2.86%
% of All Funds
3.64%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.08%
New
33
Increased
67
Reduced
73
Closed
22
Calls
$5.9M
Puts
$1.05M
Net Calls
+$4.85M
Net Calls Change
+$476K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$36.2M
2
FCM
Freshford Capital Management
New York
+$13.1M
3
Renaissance Technologies
Renaissance Technologies
New York
+$5.33M
4
N
Nuveen
North Carolina
+$4.89M
5
Neuberger Berman Group
Neuberger Berman Group
New York
+$3.79M

Top Sellers

Rank Fund Capital Flow
1
EIP
Epoch Investment Partners
New York
-$14.5M
2
RA
Royce & Associates
New York
-$9.2M
3
UBS Group
UBS Group
Switzerland
-$5.86M
4
VLKIM
Van Lanschot Kempen Investment Management
Netherlands
-$5.71M
5
BlackRock
BlackRock
New York
-$3.92M
Name Holding Trade Value Shares
Change 		Change in
Stake
MIM
101
MetLife Investment Management
New Jersey
$707K – – –
LSERS
102
Louisiana State Employees Retirement System
Louisiana
$686K -$2.7K -100 -0.5%
Qube Research & Technologies (QRT)
103
Qube Research & Technologies (QRT)
United Kingdom
$663K +$590K +21,805 New
VOYA Investment Management
104
VOYA Investment Management
Georgia
$660K -$7.79K -288 -1%
SG Americas Securities
105
SG Americas Securities
New York
$658K -$1.11M -41,060 -65%
Grantham, Mayo, Van Otterloo & Co (GMO)
106
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$657K +$584K +21,600 New
HF
107
HRT Financial
New York
$654K +$285K +10,520 +96%
SCP
108
Seizert Capital Partners
Michigan
$638K – – –
AB
109
Amalgamated Bank
New York
$634K +$33.8K +1,248 +6%
CCIA
110
Campbell & Co Investment Adviser
Maryland
$608K +$194K +7,165 +56%
AP
111
Advisor Partners
California
$599K +$3.92K +145 +0.7%
BNP Paribas Financial Markets
112
BNP Paribas Financial Markets
France
$592K -$948K -35,062 -64%
State Board of Administration of Florida Retirement System
113
State Board of Administration of Florida Retirement System
Florida
$571K -$352K -13,000 -41%
PFO
114
Pathstone Family Office
New Jersey
$566K +$503K +18,607 New
JIC
115
Johnson Investment Counsel
Ohio
$566K – – –
NYLIM
116
New York Life Investment Management
New York
$546K +$486K +17,964 New
MSRPS
117
Maryland State Retirement & Pension System
Maryland
$537K +$7.41K +274 +2%
Manulife (Manufacturers Life Insurance)
118
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$522K -$6.11K -226 -1%
Ensign Peak Advisors
119
Ensign Peak Advisors
Utah
$503K – – –
SO
120
STRS Ohio
Ohio
$501K +$27K +1,000 +6%
HW
121
Hancock Whitney
Mississippi
$500K +$325 +12 +0.1%
Allianz Asset Management
122
Allianz Asset Management
Germany
$498K -$431K -15,932 -49%
Los Angeles Capital Management
123
Los Angeles Capital Management
California
$488K -$960K -35,497 -69%
AQR Capital Management
124
AQR Capital Management
Connecticut
$478K +$111K +4,100 +35%
SEI Investments
125
SEI Investments
Pennsylvania
$474K +$421K +15,584 New
3 4
5
6 7

VIVO Hedge Fund Activity: Q2 2022 in Review

216 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q2 2022, worth a combined $1.35B — up 21% from $1.11B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new VIVO positions and 22 closed out — a net gain of 11 holders — while 67 added to existing stakes and 73 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $36.2M. The largest seller was Epoch Investment Partners, cutting an estimated $14.5M.

  • 216 institutional investors held Meridian Bioscience Inc (VIVO) as of Q2 2022, up from 210 in Q1 2022.
  • Funds reported $1.35B of Meridian Bioscience Inc stock for Q2 2022, up 21% quarter-over-quarter.
  • 33 funds opened new Meridian Bioscience Inc positions in Q2 2022 and 22 closed out, a net change of +11 holders.
  • The largest Meridian Bioscience Inc buyer in Q2 2022 was Fidelity Investments, an estimated $36.2M added.
  • The largest Meridian Bioscience Inc seller in Q2 2022 was Epoch Investment Partners, an estimated $14.5M sold.

Based on aggregated 13F filings for Q2 2022.